研究與發展
為我們的患者工作
我們的研究與發展團隊致力於發現、開發和提供可能改變患者生活的藥物，並在高度未滿足的需求領域建立新的照護標準。我們正在創造改變人生的藥物，用以消除世界上一些最棘手病症：癌症、心臟和免疫系統疾病以及血液疾病。工作內容並不容易，但所做的事獨特又有趣。您將改寫規則、解決最艱難的挑戰，並創造奇蹟。
Our next neuroscience breakthrough need authors
We are excited to re-enter the field of neuroscience, seeking innovative treatments for patients living with neuropsychiatric disorders such as schizophrenia and neurological conditions like Alzheimer’s disease. You can join us on this exciting journey to transform the lives of patients around the world. It may just transform your career.
Leading the way to scientific innovation for patients
PharmaVoice 100
OCTOBER 2024
Alyssa Johnsen, Head of Clinical Development, ICN has been honored for her leadership in clinical development.
Endpoints News Women in Biopharma R&D
OCTOBER 2024
Mariann Micsinai-Balan, VP, GBDS Data Science & Statistical Methodology has been featured for her outstanding contributions to our novel computational methods.
ACS Heroes of Chemistry Award
OCTOBER 2024
Our chemists are honored to be recognized for the ACS Heroes of Chemistry Award for the seventh time in the past ten years.
This year, we celebrate their dedicated work to deliver the first oral treatment for patients living with plaque psoriasis.
我們的職涯故事
聽聽我們世界各地研究與發展團隊成員的故事，瞭解他們每天為患者所做的工作。
Science Firsthand: Translating the promise of cell therapy
Learn the story of how chimeric antigen receptor (CAR) T cell therapy went from hypothesis to groundbreaking treatment. Committed to improving cell therapy science, BMS is advancing a robust pipeline of cell therapies.
Science Firsthand: The pathway to drug discovery
Discover the new Bristol Myers Squibb Science Firsthand series, showcasing the pioneering path of intentional protein degraders in drug discovery and development process. Read more to experience the transformative potential for life-changing breakthroughs in patient care.
English 
Japanese 
French 
German 
Italian 
Korean 
Portuguese 
Chinese (China) 
Spanish 
Chinese (Taiwan) 
